Item 5. Market for Registrant’s Common Equity
ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES
Market Information
Neogen Common Stock is traded on the NASDAQ Global Select Market under the symbol NEOG.
Holders
As of June 30, 2026, there were 459 stockholders of record of our common stock. The actual number of holders is significantly greater than this number of holders and includes stockholders who are beneficial owners but whose shares are held in street name by brokers and other nominees.
Dividends
Neogen has never paid cash dividends on its Common Stock and does not expect to pay dividends in the foreseeable future.
Issuer Purchases of Equity Securities
The following is a summary of share repurchase activity during the fourth quarter fiscal year 2026:
Period
(a) Shares Purchased
(b) Average Price Paid per Share
(c) Shares Purchased as Part of Publicly Announced Plans or Programs
(d) Maximum Number of Shares That May Yet Be Purchased Under the Plans or Programs
March 2026
—
—
—
5,900,000
April 2026
—
—
—
5,900,000
May 2026
—
—
—
5,900,000
Total
—
—
—
5,900,000
In October 2018, the Company’s Board of Directors authorized a program to purchase, subject to market conditions, up to 6,000,000 shares of the Company’s common stock. The program does not have any scheduled expiration date. The Company did not repurchase any shares pursuant to this repurchase program during the fourth quarter of fiscal 2026. As of May 31, 2026, a total of 5,900,000 shares of common stock remained available for repurchase under this program.
On May 1, 2026, we granted equity awards to a newly hired executive officer, consisting of options to purchase an aggregate of 89,520 shares of common stock at an exercise price of $9.53 per share, with three-year ratable vesting; and 39,349 restricted stock units, with a three-year vesting period.
The awards described above were granted as inducement awards in connection with the hiring of the executive. The grant of the equity awards was exempt from registration under the Securities Act of 1933, as amended, in reliance on Section 4(a)(2) thereof, as transactions by an issuer not involving a public offering.
29
Stock Performance Graph
The graph below matches Neogen Corporation’s cumulative 5-Year total shareholder return on common stock with the cumulative total returns of the NASDAQ Composite index, the S&P 500 Life Sciences Tools & Services index, and the S&P 400 Health Care index. The graph tracks the performance of a $100 investment in our common stock and in each index (with the reinvestment of all dividends) from 5/31/2021 to 5/31/2026.
5/21
5/22
5/23
5/24
5/25
5/26
Neogen Corporation
100.0
57.3
37.9
28.5
12.7
19.4
NASDAQ Composite
100.0
88.5
95.6
124.6
143.3
203.5
S&P 500 Life Sciences Tools & Services
100.0
100.2
89.0
98.5
73.3
84.4
S&P 400 Health Care
100.0
85.3
81.3
84.3
79.2
95.5
The stock price performance included in this graph is not necessarily indicative of future stock price performance.
ITEM 6. RESERVED
30